Research · Randomized controlled trial
Prophylaxis of migraine with oral magnesium: a prospective, multi-center, placebo-controlled, double-blind randomized study
What it found
Cut attack frequency 41.6% vs 15.8% placebo (a separate trial was negative — evidence is mixed).
- Design
- Randomized controlled trial
- Year
- 1996
- Sample size
- 81
- Population
- adults with migraine
- Intervention
- oral magnesium 600 mg/day
- Outcome
- attack frequency
- Journal
- Cephalalgia
Citation last checked 2026-06-21.